Clinical translation of tissue-engineered oesophageal grafts: are patients ready for us?
Topic overview
This study assessed patient and caregiver attitudes toward tissue-engineered oesophageal grafts for long-gap oesophageal atresia through an engagement event with 43 respondents. Results showed strong receptivity, with 89% comfortable with cell cultivation and perceptions significantly improving after education about the technology. The findings support establishing patient focus groups to guide clinical translation of tissue-engineered constructs for OA treatment.
Key takeaways
- 85% of OA patients/caregivers had awareness of tissue engineering, indicating readiness for clinical translation discussions.
- 89% reported no concerns about growing their own cells in a lab for tissue-engineered oesophageal grafts.
- Patient perception of tissue engineering significantly improved after education (median score 4→5, p<0.0001).
- 96% of attendees wanted involvement in focus groups for developing tissue-engineered products for oesophageal atresia.
- Early stakeholder engagement is essential for successful clinical translation of tissue-engineered constructs.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Clinical translation of tissue-engineered oesophageal grafts: are patients ready for us?. GlobalCastMD Medical Library. 2024-11-06. https://dev.library.globalcastmd.com/article/9392?via_space=staycurrentmd
Comments